Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > shorts down from 111k to 49k shares
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(37)
•••
Post by Marco321on May 06, 2022 9:43am
342 Views
Post# 34661719

shorts down from 111k to 49k shares

shorts down from 111k to 49k shares
Symbol Issue Name Shares Net Change Date
$TLT.V THERALASE TECHNOLOGIES INC. 48,822 -62,818 30 Apr 2022
$TLT.V THERALASE TECHNOLOGIES INC. 111,640 49,862 15 Apr 2022
$TLT.V THERALASE TECHNOLOGIES INC. 61,778 22,886 31 Mar 2022
$TLT.V THERALASE TECHNOLOGIES INC. 38,892 -15,755 15 Mar 2022
$TLT.V THERALASE TECHNOLOGIES INC. 54,647 -73,134 28 Feb 2022
$TLT.V THERALASE TECHNOLOGIES INC. 127,781 84,406 15 Feb 2022
$TLT.V THERALASE TECHNOLOGIES INC. 43,375 -116,010 31 Jan 2022
$TLT.V THERALASE TECHNOLOGIES INC. 159,385 88,598 15 Jan 2022
$TLT.V THERALASE TECHNOLOGIES INC. 70,787 -3,872 31 Dec 2021
$TLT.V THERALASE TECHNOLOGIES INC. 74,659 31,432 15 Dec 2021
$TLT.V THERALASE TECHNOLOGIES INC. 43,227 2,725 30 Nov 2021
$TLT.V THERALASE TECHNOLOGIES INC. 40,502 35,937 15 Nov 2021


All in my opinion
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities